세계의 소화성 궤양 시장 보고서(2025년)

Peptic Ulcer Global Market Report 2025

US $ 4,490 ￦ 6,244,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,026,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,807,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

소화성 궤양 시장 규모는 향후 몇 년 동안 안정적인 성장을 보일 것으로 예상되며, 2029년까지 3.7%의 연평균 복합 성장률(CAGR)로 49억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 새로운 치료법 및 치료 방법, 노인 인구 증가, 정밀의료의 통합, 예방 조치 및 건강 증진, 지속적인 연구 및 임상시험에 기인합니다. 예측 기간의 주요 동향으로는 디지털 헬스 솔루션, 치료 방법의 발전, 헬리코박터 파일로리 감염의 유병률 증가, 영상 진단 기술의 통합, 병용 요법 증가 등이 있습니다.

비만 유병률 증가는 향후 소화성 궤양 시장의 성장을 견인할 것으로 예상됩니다. 비만증은 체지방의 과도한 축적을 특징으로 하는 질환으로 일반적으로 체질량지수(BMI)가 30 이상으로 정의됩니다. 비만증은 식습관 장애, 운동 부족 등 유전적, 환경적, 생활습관적 요인이 복합적으로 작용하여 발병합니다. 비만은 위산 과다 분비를 유발하고 위 점막의 보호 기능을 저하시켜 소화성 궤양 발생을 촉진합니다. 또한, 과체중은 장내 염증을 증가시켜 소화성 궤양의 발생을 더욱 촉진하는 것으로 보입니다. 예를 들어, 2024년 9월 미국 질병통제예방센터는 2021년 8월부터 2023년 8월까지 성인 비만 유병률이 40.3%, 남성은 39.2%, 여성은 41.3%로 나타났습니다고 보고했습니다. 이처럼 비만 증가가 소화성 궤양 시장의 확대를 견인하고 있습니다.

흡연율 증가는 당분간 소화성 궤양 시장의 성장을 가속할 것으로 예상됩니다. 흡연은 담배나 마리화나 등 식물성 제품을 태워 증기를 흡입하는 것으로 소화성 궤양 질환의 원인으로 알려져 있습니다. 흡연은 위와 십이지장 점막을 손상시키고, 위로의 혈액 공급을 감소시키고, 위산 분비를 증가시켜 소화성 궤양의 발생률을 증가시킬 수 있습니다. 예를 들어, 2023년 6월 빅토리아 주정부가 발표한 자료에 따르면 14-17세의 현재 흡연율이 4년 만에 3배로 증가하여 2022년에는 6.7%를 나타낼 것으로 나타났습니다. 결과적으로 흡연율 증가는 소화성 궤양 시장 성장 촉진요인이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 소화성 궤양 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업 분석
• 세계의 소화성 궤양 시장 : 성장률 분석
• 세계의 소화성 궤양 시장 실적 : 규모와 성장, 2019-2024
• 세계의 소화성 궤양 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 소화성 궤양 전체 시장(TAM)

제6장 시장 세분화

• 세계의 소화성 궤양 시장 : 질환 적응증별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 위염
• 위궤양
• 십이지장 궤양
• 위식도 역류증(GERD)
• 세계의 소화성 궤양 시장약 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 양성자 펌프 억제제(PPI)
• H2 길항제
• 항생제
• 기타 약물
• 세계의 소화성 궤양 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원 약국
• 개인 클리닉
• 드럭스토어
• 소매 약국
• E-Commerce
• 세계의 소화성 궤양 시장 : 위염 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 급성 위염
• 만성 위염
• 세계의 소화성 궤양 시장 : 위궤양 유형별 분류, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 급성 위궤양
• 만성 위궤양
• 세계의 소화성 궤양 시장 : 십이지장 궤양 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 급성 십이지장 괴양
• 만성 십이지장 괴양
• 세계의 소화성 궤양 시장위식도 역류증(GERD)별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 비등응성 위식도 역류증
• 등응성 위식도 역류증

제7장 지역별/국가별 분석

• 세계의 소화성 궤양 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 소화성 궤양 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 소화성 궤양 시장 : 경쟁 구도
• 소화성 궤양 시장 : 기업 개요
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Sanofi S.A
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• CSL Limited
• Boehringer Ingelheim International GmbH
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Company
• Dr. Reddy's Laboratories Ltd.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 소화성 궤양 시장(2029년) : 새로운 기회를 제공하는 국가
• 소화성 궤양 시장(2029년) : 새로운 기회를 제공하는 부문
• 소화성 궤양 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

An open sore or raw area in the stomach lining or intestine is known as a peptic ulcer. It is primarily a result of the erosion of the protective lining of the stomach or the upper part of the small intestine, known as the duodenum. Common symptoms of peptic ulcers include upper abdominal pain or discomfort and symptoms of acid reflux, such as heartburn, sometimes accompanied by nausea.

The primary disease indications consist of gastritis, gastric ulcers, duodenal ulcers, and gastroesophageal reflux disease (GERD). Gastritis is a medical condition characterized by inflammation, irritation, or erosion of the stomach lining. The typical approach to treating gastritis involves medications such as proton pump inhibitors and lifestyle adjustments. The drugs utilized include proton pump inhibitors (PPI), H2 antagonists, antibiotics, and other pharmaceuticals, which are distributed through various channels such as hospital pharmacies, private clinics, drug stores, retail pharmacies, and e-commerce.

The peptic ulcer market research report is one of a series of new reports from The Business Research Company that provides peptic ulcer market statistics, including peptic ulcer industry global market size, regional shares, competitors with a peptic ulcer market share, detailed peptic ulcer market segments, market trends and opportunities, and any further data you may need to thrive in the peptic ulcer industry. This peptic ulcer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peptic ulcer market size has grown steadily in recent years. It will grow from $4.1 billion in 2024 to $4.24 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to increased prevalence of helicobacter pylori infection, rising use of nonsteroidal anti-inflammatory drugs (NSAIDs), changing lifestyles and dietary habits, awareness campaigns and educational initiatives, focus on stress management.

The peptic ulcer market size is expected to see steady growth in the next few years. It will grow to $4.91 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to emerging therapies and treatment modalities, increasing geriatric population, integration of precision medicine, preventive measures and health promotion, continued research and clinical trials. Major trends in the forecast period include digital health solutions, advancements in treatment modalities, increasing prevalence of helicobacter pylori infection, integration of diagnostic imaging technologies, increasing use of combination therapies.

The rising incidence of obesity is anticipated to drive the growth of the peptic ulcer market in the future. Obesity is a medical condition marked by an excessive accumulation of body fat, typically defined as having a body mass index (BMI) of 30 or higher. It can arise from a combination of genetic, environmental, and lifestyle factors, including poor dietary habits and insufficient physical activity. Obesity leads to an overproduction of stomach acid, compromises the protective mucosal lining of the stomach, and contributes to the development of peptic ulcers. Additionally, excess weight appears to increase inflammation in the gut, which can further facilitate the emergence of peptic ulcers. For example, in September 2024, the Centers for Disease Control and Prevention, a U.S.-based public health agency, reported that between August 2021 and August 2023, the prevalence of obesity among adults was 40.3%, with rates of 39.2% in men and 41.3% in women. Thus, the increasing prevalence of obesity is driving the expansion of the peptic ulcer market.

The escalating rates of smoking are expected to fuel the peptic ulcer market's growth in the foreseeable future. Smoking, the inhalation of vapors from burning plant-based products such as tobacco or marijuana, is a well-established contributor to peptic ulcer disease. Smoking harms the stomach and duodenal linings, reduces blood supply to the stomach, and increases stomach acid production, elevating the incidence of peptic ulcers. For example, data from Quit Victoria in June 2023 highlighted a threefold increase in current cigarette smoking among 14-17-year-olds over four years, reaching 6.7% in 2022. Consequently, the rising smoking rates serve as a driving factor for the peptic ulcer market.

Companies in the peptic ulcer market are focusing on developing innovative products and solutions, obtaining approval from federal agencies to secure a competitive advantage. The development of drugs is essential for managing and treating peptic ulcers, as it helps with symptom management, healing, preventing complications, and addressing the underlying issues. For example, in April 2023, Akums Drugs and Pharmaceutical Ltd., a pharmaceutical formulations and active pharmaceutical ingredients (APIs) company based in India, launched its new formulation, the Combikit, which combines Amoxicillin, Clarithromycin, and Esomeprazole. This Combikit has been approved by the Central Drugs Standard Control Organisation (CDSCO) for the treatment of duodenal ulcers associated with Helicobacter pylori (H. pylori) and for the eradication of H. pylori in patients with either active or healed peptic ulcers. The therapy targeting H. pylori has shown effectiveness in reducing the risk of ulcer recurrence, providing significant advantages to patients. H. pylori is a common infection in India and is linked to the development of gastritis and peptic ulcers.

In July 2022, Juvise Pharmaceuticals, a France-based pharmaceutical company, acquired the global commercial rights to Pylera from AbbVie Inc. for $408 million (€400 million). Pylera, an antimicrobial tri-therapy, targets peptic ulcers caused by Helicobacter pylori (H. pylori) infection. This acquisition is expected to facilitate Juvise Pharmaceuticals' expansion of its gastro-intestinal medicine product portfolio, serving as a strategic addition for geographic expansion. AbbVie Inc., a U.S.-based pharmaceutical company, specializes in providing various medications for diverse conditions, including peptic ulcers.

Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

North America was the largest region in the peptic ulcer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the peptic ulcer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The peptic ulcer market consists of revenues earned by entities by providing treatment services related to peptic ulcer such as surgeries, endoscopy, blood tests, and physical exams. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptic ulcer market also includes sales of acid blockers, cytoprotective agents, bismuth subsalicylate, and mastic powder. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peptic Ulcer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peptic ulcer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peptic ulcer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptic ulcer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Indication: Gastritis; Gastric Ulcer; Duodenal Ulcer; Gastroesophageal Reflux Disease (GERD)
• 2) By Drug Type: Proton Pump Inhibitors (PPI); H2 Antagonists; Antibiotics; Other Drugs
• 3) By Distribution Channel: Hospital Pharmacies; Private Clinics; Drug Store; Retail Pharmacies; E-Commerce
• Subsegments:
• 1) By Gastritis: Acute Gastritis; Chronic Gastritis
• 2) By Gastric Ulcer: Acute Gastric Ulcer; Chronic Gastric Ulcer
• 3) By Duodenal Ulcer: Acute Duodenal Ulcer; Chronic Duodenal Ulcer
• 4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD; Erosive GERD
• Companies Mentioned: Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Peptic Ulcer Market Characteristics

3. Peptic Ulcer Market Trends And Strategies

4. Peptic Ulcer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Peptic Ulcer Growth Analysis And Strategic Analysis Framework

• 5.1. Global Peptic Ulcer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Peptic Ulcer Market Growth Rate Analysis
• 5.4. Global Peptic Ulcer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Peptic Ulcer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Peptic Ulcer Total Addressable Market (TAM)

6. Peptic Ulcer Market Segmentation

• 6.1. Global Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gastritis
• Gastric Ulcer
• Duodenal Ulcer
• Gastroesophageal Reflux Disease (GERD)
• 6.2. Global Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proton Pump Inhibitors (PPI)
• H2 Antagonists
• Antibiotics
• Other Drugs
• 6.3. Global Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Private Clinics
• Drug Store
• Retail Pharmacies
• E-Commerce
• 6.4. Global Peptic Ulcer Market, Sub-Segmentation Of Gastritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Gastritis
• Chronic Gastritis
• 6.5. Global Peptic Ulcer Market, Sub-Segmentation Of Gastric Ulcer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Gastric Ulcer
• Chronic Gastric Ulcer
• 6.6. Global Peptic Ulcer Market, Sub-Segmentation Of Duodenal Ulcer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Duodenal Ulcer
• Chronic Duodenal Ulcer
• 6.7. Global Peptic Ulcer Market, Sub-Segmentation Of Gastroesophageal Reflux Disease (GERD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Erosive GERD
• Erosive GERD

7. Peptic Ulcer Market Regional And Country Analysis

• 7.1. Global Peptic Ulcer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Peptic Ulcer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peptic Ulcer Market

• 8.1. Asia-Pacific Peptic Ulcer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peptic Ulcer Market

• 9.1. China Peptic Ulcer Market Overview
• 9.2. China Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peptic Ulcer Market

• 10.1. India Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peptic Ulcer Market

• 11.1. Japan Peptic Ulcer Market Overview
• 11.2. Japan Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peptic Ulcer Market

• 12.1. Australia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peptic Ulcer Market

• 13.1. Indonesia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peptic Ulcer Market

• 14.1. South Korea Peptic Ulcer Market Overview
• 14.2. South Korea Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peptic Ulcer Market

• 15.1. Western Europe Peptic Ulcer Market Overview
• 15.2. Western Europe Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peptic Ulcer Market

• 16.1. UK Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peptic Ulcer Market

• 17.1. Germany Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peptic Ulcer Market

• 18.1. France Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peptic Ulcer Market

• 19.1. Italy Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peptic Ulcer Market

• 20.1. Spain Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peptic Ulcer Market

• 21.1. Eastern Europe Peptic Ulcer Market Overview
• 21.2. Eastern Europe Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peptic Ulcer Market

• 22.1. Russia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peptic Ulcer Market

• 23.1. North America Peptic Ulcer Market Overview
• 23.2. North America Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peptic Ulcer Market

• 24.1. USA Peptic Ulcer Market Overview
• 24.2. USA Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peptic Ulcer Market

• 25.1. Canada Peptic Ulcer Market Overview
• 25.2. Canada Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peptic Ulcer Market

• 26.1. South America Peptic Ulcer Market Overview
• 26.2. South America Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peptic Ulcer Market

• 27.1. Brazil Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peptic Ulcer Market

• 28.1. Middle East Peptic Ulcer Market Overview
• 28.2. Middle East Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peptic Ulcer Market

• 29.1. Africa Peptic Ulcer Market Overview
• 29.2. Africa Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peptic Ulcer Market Competitive Landscape And Company Profiles

• 30.1. Peptic Ulcer Market Competitive Landscape
• 30.2. Peptic Ulcer Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Peptic Ulcer Market Other Major And Innovative Companies

• 31.1. Sanofi S.A
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca plc
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. CSL Limited
• 31.11. Boehringer Ingelheim International GmbH
• 31.12. Eisai Co. Ltd.
• 31.13. Sun Pharmaceutical Industries Ltd.
• 31.14. Otsuka Pharmaceutical Company
• 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Peptic Ulcer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peptic Ulcer Market

34. Recent Developments In The Peptic Ulcer Market

35. Peptic Ulcer Market High Potential Countries, Segments and Strategies

• 35.1 Peptic Ulcer Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Peptic Ulcer Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Peptic Ulcer Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료